Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease (CLD) worldwide and inflammation is key to its progression/resolution. As we have previously described that rilpivirine (RPV) is hepatoprotective in murine models of CLD, here we determine the molecular mecha...

Full description

Bibliographic Details
Main Authors: Angela B. Moragrega, Aleksandra Gruevska, Isabel Fuster-Martínez, Ana M. Benedicto, Joan Tosca, Cristina Montón, Victor M. Victor, Juan V. Esplugues, Ana Blas-García, Nadezda Apostolova
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Liver disease
Inflammation
Rilpivirine
Leukocytes
Macrophages
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223013355

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223013355

Similar Items